| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 09/28/2011 | CN102199139A Liquid crystalline compounds and liquid crystalline media |
| 09/28/2011 | CN102199121A 4-(4-(3-trifluoro methyl) benzamido phenoxyl)-2-(methyl carbamyl) pyridine salt, its preparation method and application |
| 09/28/2011 | CN102199120A Method for synthesizing 2,2'-bipyridine-4,4'-dicarboxylic acid |
| 09/28/2011 | CN102199096A Method for synthesizing organic ionic compounds |
| 09/28/2011 | CN102199095A Substituted diphenylamine compounds and preparation and application thereof |
| 09/28/2011 | CN101538289B Monomer for organic electro-phosphorescent polymer |
| 09/28/2011 | CN101531631B Substituted pyridinones as modulators of p38 map kinase |
| 09/28/2011 | CN101516848B N'-cyano-N-alkyl halide imide amide derivatives |
| 09/28/2011 | CN101270083B Method for preparing nicotinamide in high temperature liquid water medium with nicotinamine non-catalysis hydrolyzation |
| 09/27/2011 | US8026371 Hydroxamates as therapeutic agents |
| 09/27/2011 | US8026364 NK1 antagonists |
| 09/27/2011 | US8026261 Fluorinated derivatives of deferiprone |
| 09/27/2011 | US8026258 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 09/27/2011 | US8026239 Cell differentiation inducer |
| 09/27/2011 | US8025988 Reactive organometallic dendrimers |
| 09/27/2011 | CA2475930C 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6 |
| 09/27/2011 | CA2457410C Compounds effecting glucokinase |
| 09/27/2011 | CA2370206C Pharmaceutical compositions for inhibition of cytokine production and secretion |
| 09/22/2011 | WO2011115378A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 09/22/2011 | WO2011115163A1 1,2,4,5-substituted phenyl derivative, method for producing same and organic electroluminescent element having same as constituent component |
| 09/22/2011 | WO2011115069A1 Exhaustive searching for crystals |
| 09/22/2011 | WO2011113894A1 Pyridine and pyrazine derivative for the treatment of cf |
| 09/22/2011 | WO2011113370A1 Deuterium-substituted omega-diphenylurea and derivatives thereof and pharmaceutical compositions comprising these compounds |
| 09/22/2011 | WO2011113368A1 Preparation method of fluoro-substituted deuterated diphenylurea |
| 09/22/2011 | WO2011113367A1 Method and process for preparation and production of deuterated ω-diphenylurea |
| 09/22/2011 | WO2011113366A1 Method for preparing deuterated diphenylurea |
| 09/22/2011 | WO2011113203A1 Deuterium-substituted omega-diphenylurea and derivatives thereof and pharmaceutical compositions comprising the compounds |
| 09/22/2011 | WO2011025982A3 Tetracycline compounds |
| 09/22/2011 | US20110230517 Calcium receptor modulating agents |
| 09/22/2011 | US20110230483 Pyridine and Pyrazine derivative for the Treatment of CF |
| 09/22/2011 | US20110230465 Viral polymerase inhibitors |
| 09/22/2011 | US20110230452 Compounds and methods for the treatment of pain and other diseases |
| 09/22/2011 | US20110230446 Cathepsin cysteine protease inhibitors |
| 09/22/2011 | US20110230350 Aryl-and hetarylsulfonamides as active ingredients against abiotic plant stress |
| 09/22/2011 | US20110229410 Technetium-dipyridine complexes, and methods of use thereof |
| 09/22/2011 | CA2793594A1 Method and process for preparation and production of deuterated .omega.-diphenylurea |
| 09/22/2011 | CA2793392A1 Pyridine and pyrazine derivative for the treatment of cf |
| 09/21/2011 | EP2367001A1 Biospecific binding reactants labeled with new luminescent lanthanide chelates and their use |
| 09/21/2011 | EP2366691A1 The nitropyridinyl ethyleneimine compound, the pharmaceutical composition containing it, the preparation method and use thereof |
| 09/21/2011 | EP2365965A1 Process for manufacturing substituted 3-pyridylmethyl ammonium bromides |
| 09/21/2011 | EP2155683B8 Pyridone derivatives as p38a mapk inhibitors |
| 09/21/2011 | EP1798222B1 Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery |
| 09/21/2011 | EP1487428B1 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 09/21/2011 | CN201978534U Automatic liquid discharge device of extraction tower for production and oscillation of 3-cyanopyridine |
| 09/21/2011 | CN102190683A Phosphorous anion ionic liquid and preparation method thereof |
| 09/21/2011 | CN102190625A Stilbene tumor targeted medicine Combretastatin A4 analogs |
| 09/21/2011 | CN102190624A Sulfur-containing/nitrogen-group-containing ionic liquid and preparation method thereof |
| 09/21/2011 | CN102190616A Method and process for synthesizing and producing deuterated omega-diphenyl urea |
| 09/21/2011 | CN102190587A Method and process for synthesizing and producing deuterated methylamine and salts thereof |
| 09/21/2011 | CN101343250B Thrombopoietin mimetics |
| 09/20/2011 | US8022248 3-[2-(3-Cyanophenoxy)-4-(trifluoromethyl)phenyl]propanoic acid;prostaglandin D2 inhibitor, orphan receptor CRTH2 antagonist; antiinflammatory, analgesic, antipyretic; respiratory system disorders: asthma and rhinitis; coupling amino/thio-phenyl derivatives with ester followed by hydrolysis to acid |
| 09/20/2011 | US8022212 Light-emitting element and iridium complex |
| 09/20/2011 | US8022208 Benzene derivative or salt thereof |
| 09/20/2011 | US8022087 Derivatives of pyridone and use thereof |
| 09/20/2011 | US8022079 Methods of modulating PPAR gamma-type receptors |
| 09/20/2011 | US8022064 Phenylpentadienoyl derivatives and their use as PAR 1 antagonists |
| 09/20/2011 | CA2669311C Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof |
| 09/20/2011 | CA2548668C Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 09/20/2011 | CA2476067C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 09/20/2011 | CA2471943C .beta.-amyloid protein production-secretion inhibitors |
| 09/20/2011 | CA2454302C Method for controlling particular insect pests by applying anthranilamide compounds |
| 09/20/2011 | CA2440067C Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same |
| 09/20/2011 | CA2417904C Compounds acting as melanocortin receptor ligands |
| 09/20/2011 | CA2411726C Use of ingenanes in treating a pkc-related condition or disorder |
| 09/20/2011 | CA2115828C Calcium receptor active molecules |
| 09/15/2011 | WO2011111930A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 09/15/2011 | WO2011111831A1 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative |
| 09/15/2011 | WO2011111705A1 PROCESS FOR PREPARATION OF t-BUTOXYCARBONYLAMINE COMPOUNDS |
| 09/15/2011 | WO2011110824A1 Bis aromatic compounds for use as ltc4 synthase inhibitors |
| 09/15/2011 | WO2011110612A1 Inhibitors of protein kinases |
| 09/15/2011 | US20110224439 Process for Manufacturing 5-Chloromethyl-2,3-Pyridine Dicarboxylic Acid Anhydrides |
| 09/15/2011 | US20110224433 Process for Manufacturing Substituted 3-pyridylmethyl Ammonium Bromides |
| 09/15/2011 | US20110224266 4 aminopyridine and a pharmaceutical composition for treatment of neuronal disorders |
| 09/15/2011 | US20110224225 Inhibitors of protein kinases |
| 09/15/2011 | US20110224213 Use of Glutaric Acid Derivatives or the Pharmaceutically Acceptable Salts Thereof as Anti-Arrhythmic Agents |
| 09/15/2011 | US20110224189 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 09/15/2011 | US20110224156 Propionic Acids, Propionic Acid Esters, and Related Compounds |
| 09/15/2011 | US20110223093 Ionic liquid systems for carbon dioxide and sulfur dioxide removal |
| 09/15/2011 | CA2789189A1 Inhibitors of protein kinases |
| 09/14/2011 | EP2365735A2 Luminescent element material and luminescent element comprising the same |
| 09/14/2011 | EP2364973A1 Heterocyclic inhibitors of MEK and Methods of use thereof |
| 09/14/2011 | EP2364971A2 2,5-Disubstituted pyridines for the preparation of 2-substituted 5-(1-alkylthio)-alkylpyridines |
| 09/14/2011 | EP2364735A2 Branched PEG conjugates of GLP-1 |
| 09/14/2011 | EP2364297A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders |
| 09/14/2011 | EP2364082A1 Naphthamides as anticancer agents |
| 09/14/2011 | EP2225241B1 Derivatives of N-phenyl-imidazo-(1,2-A)-pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/14/2011 | EP1689387B1 Bicyclic inhibitors of mek and methods of synthesis thereof |
| 09/14/2011 | EP1481978B1 Process for production of heteroaryl-type boron compounds with iridium catalyst |
| 09/14/2011 | EP1377551B1 Antiproliferative agents |
| 09/14/2011 | CN1918146B Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 09/14/2011 | CN1642551B Inhibitors of histone deacetylase |
| 09/14/2011 | CN1612861B Ecl labels having improved non-specific binding properties, methods of using and kits containing the same |
| 09/14/2011 | CN102186824A Fused-ring derivative and medical application of same |
| 09/14/2011 | CN102186823A Heterocyclic antiviral arylpyridone derivatives |
| 09/14/2011 | CN102186822A Novel urea and thiourea derivatives |
| 09/14/2011 | CN102186821A Pentacyclic liquid crystal compound having nitrogen-containing heterocyclic ring, liquid crystal composition, and liquid crystal display element |
| 09/14/2011 | CN102186813A Organosulfur compound, process for producing the same, and organic electroluminescence element using the same |
| 09/14/2011 | CN102186803A Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors |
| 09/14/2011 | CN102186476A Tryptophan hydroxylase inhibitors and methods of their use |
| 09/14/2011 | CN102181880A Selective electrolysis hydrogenation and dechlorination method for chlorinated organic matter |